Condition category
Nutritional, Metabolic, Endocrine
Date applied
Date assigned
Last edited
Retrospectively registered
Overall trial status
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Type 2 diabetes is a long-term condition where the body doesn’t produce enough insulin to function properly or, alternatively, the cells of the body don’t react well to insulin. This can cause blood sugar levels to become too high and, if left untreated, can lead to a number of health problems including heart disease, stroke, kidney disease, eyesight problems and nerve damage. People with type 2 diabetes have to look after their health very carefully. This includes eating a healthy diet, taking regular exercise, limiting the amount of alcohol they drink and making sure that they know when to seek medical attention for any health concerns that they may have. Here, we want to test a new self-help programme (diabetes self-efficacy enhancing intervention) for people who have type 2 diabetes. We want to see if the intervention leads to improvements in patients feeling more confident about managing their condition, psychological wellbeing and self-care management behaviours.

Who can participate?
Jordanian patients aged at least 20 years, diagnosed with type 2 diabetes and being treated at the diabetes specialized centre in Amman-Jordan.

What does the study involve?
Participants are randomly allocated into one of two groups. Those in group 1 (intervention group) receive their usual care and the new diabetes self-efficacy enhancing intervention. Those in group 2 (control group) receive their usual care. The intervention consists of watching a DVD, diabetes self-care management booklets, two counselling sessions and follow-up telephone calls.

What are the possible benefits and risks of participating?
There are several potential benefits to this study.. The intervention is designed to help people self-manage their disease and maintain a healthy lifestyle, solve problems and make an action plan. Risks are minimal. Patients displaying psychological stress will be informed by the researcher to stop participating in the trial.

Where is the study run from?
The University of Jordan (Jordan)

When is the study starting and how long is it expected to run for?
May 2014 to December 2014.

Who is funding the study?
Investigator initiated and funded (Jordon)

Who is the main contact?
Mrs Zainab Albikawi

Trial website

Contact information



Primary contact

Mrs Zainab Albikawi


Contact details


Additional identifiers

EudraCT number number

Protocol/serial number


Study information

Scientific title

The effect of diabetes self efficacy enhancing intervention on diabetes self care management behaviors and psychological wellbeing among Jordanian type two diabetes patients: a randomized clinical trial


Study hypothesis

1. Patients who participated in diabetes self efficacy enhancing intervention (DSEEIP) had higher levels of DM (diabetes mellitis) self care management behaviors following completion of the DSEEIP at 10 weeks post-intervention, and at a three month post-intervention follow-up evaluation, than who did not receive the intervention.
2. Patients who participated in diabetes self efficacy enhancing intervention (DSEEIP) had higher levels of DM self-efficacy following completion of the DSEEIP at 2 weeks post-intervention, and at a three month post-intervention follow-up evaluation, than who did not receive the intervention.
3. Patients who participated in diabetes self efficacy enhancing intervention (DSEEIP) will have higher levels of psychological wellbeing following completion of the DSEEIP at 2 weeks post-intervention, and at a three month post-intervention follow-up evaluation, than who did not receive the intervention
3.1. Additional Question
Are there differences in the control and intervention group baseline scores for the three outcome variables based on the demographic and disease history data?

Ethics approval

University of Jordon Ethical Committee, December 2013

Study design

Randomized controlled trial design

Primary study design


Secondary study design

Randomised controlled trial

Trial setting


Trial type


Patient information sheet

Demographic data sheet


Type two diabetes mellitis


The study intervention is based on self efficacy theory and consists of:
1. DVD, “Diabetes Self care management” booklets
2. Two rehearsal counseling sessions
3. Follow-up telephone calls

Intervention type



Not Applicable

Drug names

Primary outcome measures

Study VariableInstruments:
1. Self –Efficacy: The Diabetes Self efficacy Scale.
2. Self care management: Summary of Diabetes Self care management Activities (SDSCA), 12 items.
3. Psychological wellbeing: An Arabic version of the Depression Anxiety Stress Scales, DASS-21
4. The Demographic and disease history Questionnaire: Constructed by the current study researcher

The time points for data collection are as the following:screening (pre -intervention or baseline), 2 weeks following screening (post intervention), and 3 months follow up.

Secondary outcome measures


Overall trial start date


Overall trial end date


Reason abandoned


Participant inclusion criteria

1. Patients should satisfied clinical criteria for DM2 (diabetes type 2)
2. Patient with DM2 who are taking oral agents
3. Patient can be at any stage of their DM diagnosis, length of diagnosis is not a limiting factor in recruitment
4. Patients are required to speak and read Arabic
5. Patients are required to be equal or over the age of 20 years
6. To be eligible for participation in the current study, the patients had to have average score of less than 6.5 out of 8 on DSES
7. Patients are required to have a telephone or mobile in their residence and able to use it effectively

Participant type


Age group




Target number of participants


Participant exclusion criteria

1. Patients had major complications which would interfere with self-care management behaviors (e.g. legally blind, severe stroke, or undertaking kidney dialysis); patients health records will be checked for the presence of any major DM complications
2. Patients currently managing blood glucose levels with the use of insulin injections alone
3. Patients with cognitive impairment
4. Patients who are not able to communicate
5. Patient with any mental or psychiatric illness, patients health records will be checked for that.

Recruitment start date


Recruitment end date



Countries of recruitment


Trial participating centre


Sponsor information


The University of Jordan (Jordan)

Sponsor details

c/o Zainab Albikawi

Sponsor type




Funder type


Funder name

Investigator initiated and funded (Jordan)

Alternative name(s)

Funding Body Type

Funding Body Subtype


Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes